These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 28750432

  • 1. Hyperthyroidism in Patients with Graves' Ophthalmopathy, and Thyroidal, Skeletal and Eye Muscle Specific Type 2 Deiodinase Enzyme Activities.
    Molnár I, Szentmiklósi JA, Somogyiné-Vári É.
    Exp Clin Endocrinol Diabetes; 2017 Sep; 125(8):514-521. PubMed ID: 28750432
    [Abstract] [Full Text] [Related]

  • 2. Effect of antithyroid drugs on the occurrence of antibodies against type 2 deiodinase (DIO2), which are involved in hyperthyroid Graves' disease influencing the therapeutic efficacy.
    Molnár I, Szentmiklósi JA, Gesztelyi R, Somogyiné-Vári É.
    Clin Exp Med; 2019 May; 19(2):245-254. PubMed ID: 30610492
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical studies using immunized Guinea pig sera with features of anti-human thyroid, eye and skeletal antibody and Graves' sera.
    Molnár I, Szombathy Z, Kovács I, Szentmiklósi AJ.
    J Clin Immunol; 2007 Mar; 27(2):172-80. PubMed ID: 17243008
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J, Hosoya T, Naito N, Yoshimura H, Kohno Y, Tarutani O, Kuma K, Sakane S, Takeda K, Mozai T.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
    Penta L, Muzi G, Cofini M, Leonardi A, Lanciotti L, Esposito S.
    Int J Environ Res Public Health; 2019 Jan 08; 16(1):. PubMed ID: 30626069
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
    Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF.
    Clin Endocrinol (Oxf); 2000 Mar 08; 52(3):267-71. PubMed ID: 10718823
    [Abstract] [Full Text] [Related]

  • 11. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
    Molnár I, Balázs C.
    Acta Med Hung; 1991 Mar 08; 48(1-2):13-21. PubMed ID: 1813853
    [Abstract] [Full Text] [Related]

  • 12. Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with 3,5,3'-triiodothyronine-predominant Graves' disease.
    Ito M, Toyoda N, Nomura E, Takamura Y, Amino N, Iwasaka T, Takamatsu J, Miyauchi A, Nishikawa M.
    Eur J Endocrinol; 2011 Jan 08; 164(1):95-100. PubMed ID: 20937676
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sight-Threatening Graves' Ophthalmopathy during the Third Trimester of Pregnancy: A Case Report.
    Sakurai K, Inoue T, Niitsuma S, Sato R, Takahashi K, Arihara Z.
    Tohoku J Exp Med; 2020 Dec 08; 252(4):321-327. PubMed ID: 33268601
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.
    Wiersinga WM, Smit T, van der Gaag R, Koornneef L.
    J Endocrinol Invest; 1988 Sep 08; 11(8):615-9. PubMed ID: 2907524
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.